Overview

Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia

Status:
Not yet recruiting
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if Dostarlimab is an effective treatment for Gestational Trophoblastic Neoplasia (GTN).
Phase:
Phase 2
Details
Lead Sponsor:
University of Miami
Collaborator:
GlaxoSmithKline